Type 2 diabetes and polycystic ovary syndrome

被引：19
|
作者：
Legro, Richard S. [1 ]
机构：
[1] Penn State Univ, Coll Med, MS Hershey Med Ctr, Dept Obstet & Gynecol, Hershey, PA 17033 USA
来源：
FERTILITY AND STERILITY | 2006年 / 86卷
关键词：
polycystic ovary syndrome; hyperandrogenism; insulin resistance; diabetes; anovulation;
D O I：
10.1016/j.fertnstert.2006.04.010
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Women with polycystic ovary. syndrome (PCOS) have multiple factors that contribute to increased diabetes risk, including: insulin resistance, beta-cell dysfunction, obesity, especially centripetal obesity, family history of type 2 diabetes, and personal history of gestational-diabetes. Additionally there is some evidence to suggest that polycystic ovaries and chronic anovulation per se are risk factors. Identifying glucose intolerance and treating it are important aspects of the, care for women with PCOS.
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 50 条
  • [21] The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome
    Kakoly, Nadira S.
    Earnest, Arul
    Teede, Helena J.
    Moran, Lisa J.
    Joham, Anju E.
    DIABETES CARE, 2019, 42 (04) : 560 - 567
  • [22] Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?
    Sim, Stephanie Y. T.
    Chin, Sian L.
    Tan, Jocelyn L. K.
    Brown, Suzanne J.
    Cussons, Andrea J.
    Stuckey, Bronwyn G. A.
    FERTILITY AND STERILITY, 2016, 106 (05) : 1258 - 1263
  • [23] Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome
    Galazis, Nicolas
    Afxentiou, Thalia
    Xenophontos, Mikalena
    Diamanti-Kandarakis, Evanthia
    Atiomo, William
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 168 (02) : R33 - R43
  • [24] Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus
    Duan, Liyun
    An, Xuedong
    Zhang, Yuehong
    Jin, De
    Zhao, Shenghui
    Zhou, Rongrong
    Duan, Yingying
    Zhang, Yuqing
    Liu, Xinmin
    Lian, Fengmei
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 142
  • [25] Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes mellitus
    Peppard, HR
    Marfori, J
    Iuorno, MJ
    Nestler, JE
    DIABETES, 2001, 50 : A481 - A481
  • [26] Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review
    Livadas, Sarantis
    Anagnostis, Panagiotis
    Bosdou, Julia K.
    Bantouna, Dimitra
    Paparodis, Rodis
    WORLD JOURNAL OF DIABETES, 2022, 13 (01) : 5 - 26
  • [27] Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes
    Saxena, R.
    Welt, C. K.
    ACTA DIABETOLOGICA, 2013, 50 (03) : 451 - 457
  • [28] Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome
    Glintborg, Dorte
    Kolster, Naja Due
    Ravn, Pernille
    Andersen, Marianne Skovsager
    BIOMEDICINES, 2022, 10 (06)
  • [29] Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes
    R. Saxena
    C. K. Welt
    Acta Diabetologica, 2013, 50 : 451 - 457
  • [30] Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes
    Amini, Massoud
    Horri, Negar
    Farmani, Mahboubeh
    Haghighi, Sassan
    Sattari, Ghoshtasb
    Pornaghshband, Zahra
    Aminorroaya, Ashraf
    GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (08) : 423 - 427
12345